Hayato Ogura

Statistics

Publications

Citations

316

H-Index

Active since

2009

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

Japan Society of Chemotherapy

Hayato Ogura is an author at Japanese Foundation For Cancer Research specializing in oncogenic signaling pathways, oncology, and tyrosine kinase inhibitors.

Publications per year

2009–2017

Publications

A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations

Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda et al. · Blood · 2017 · 148 citations

Medicine, Oncology, Chemotherapy +7

Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers

Miho J. Fuse, Koutaroh Okada, Tomoko Oh‐hara et al. · Molecular Cancer Therapeutics · 2017 · 110 citations

Medicine, Oncology, Pharmacology +15

Development of a fluorescent chelating ligand for gallium ion having a quinazoline structure with two Schiff base moieties

Junko Kimura, Hiroshi Yamada, Hayato Ogura et al. · Analytica Chimica Acta · 2009 · 41 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity

Hayato Ogura, Yuka Nagatake-Kobayashi, Jun Adachi et al. · Scientific Reports · 2017 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4